Multiple Myeloma working group


Composition

Chair

Prof. Dr. P. Sonneveld (Erasmus MC, Rotterdam)

Vice-chair

Prof. Dr. S. Zweegman (AmsterdamUMC – Vumc, Amsterdam)

Secretary

Prof. Dr. N. W.C.J. van de Donk (AmsterdamUMC – Vumc, Amsterdam)


Key objectives of working group

The key objectives of this working group are:

  • To draw up guidelines for the treatment and diagnosis of multiple myeloma and related disorders including AL amyloidosis and M. Waldenström
  • Initiation and implementation of multicenter phase II and phase III clinical trials amongst younger and older patients
  • The related standardization of modern methods for determining risk profiles including cytogenetics and gene expression profiling
  • The further elaboration of collaboration with international study groups including the EMN, IFM, GIMEMA, GMMG and the Nordic group
  • Maintaining and further expanding an internationally-competitive position in respect of research into new medicines in clinical trials

Meetings & Minutes

Please note the section where meetings dates & minutes are shown are only accessible after log in.

This content is restricted. Please log in.
This content is restricted. Please log in.
Up